The Aflibercept-Induced MicroRNA Profile in the Vitreous of Proliferative Diabetic Retinopathy Patients Detected by Next-Generation Sequencing

Purpose: Vascular endothelial growth factor-A (VEGF-A) is an important pathogenic factor in proliferative diabetic retinopathy (PDR), and aflibercept (Eylea) is one of the widely used anti-VEGF agents.This study investigated the microRNA (miRNA) profiles LeatherR in the vitreous of 5 idiopathic macular hole patients (non-diabetic controls), 5 untre

read more